• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难治性精神分裂症患者。

Treatment-resistant schizophrenic patients.

作者信息

Kane J M

机构信息

Department of Psychiatry, Hillside Hospital, Glen Oaks, NY 11004, USA.

出版信息

J Clin Psychiatry. 1996;57 Suppl 9:35-40.

PMID:8823348
Abstract

Despite the proven efficacy of antipsychotic medication in the treatment of schizophrenia, a substantial proportion of patients derive little if any benefit from traditional medications. Though alternative strategies (e.g., increasing dosage, switching antipsychotic, or adding adjunctive medication) are frequently employed, success rates are often disappointing. Clozapine has shown to be effective in some poor or partially responsive patients in three prospective, random assignment, double-blind trials. Risperidone has not yet been extensively studied in treatment-resistant patients, but may also be a useful alternative.

摘要

尽管抗精神病药物在治疗精神分裂症方面的疗效已得到证实,但相当一部分患者从传统药物中获益甚微或几乎没有获益。尽管经常采用替代策略(例如增加剂量、更换抗精神病药物或添加辅助药物),但成功率往往令人失望。在三项前瞻性、随机分组、双盲试验中,氯氮平已证明对一些疗效不佳或部分有反应的患者有效。利培酮尚未在难治性患者中进行广泛研究,但也可能是一种有用的替代药物。

相似文献

1
Treatment-resistant schizophrenic patients.难治性精神分裂症患者。
J Clin Psychiatry. 1996;57 Suppl 9:35-40.
2
A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.氯氮平与利培酮联合治疗精神分裂症患者的双盲研究:对认知的影响。
J Clin Psychiatry. 2006 Dec;67(12):1912-9.
3
Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.利培酮辅助治疗氯氮平抵抗性精神分裂症:一例病例报告及文献综述
Clin Neuropharmacol. 2007 Mar-Apr;30(2):114-21. doi: 10.1097/01.wnf.0000240947.51994.96.
4
Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.精神分裂症随机非典型抗精神病药物试验中的对照组偏倚。
Arch Gen Psychiatry. 2005 Sep;62(9):961-70. doi: 10.1001/archpsyc.62.9.961.
5
Management of treatment-resistant patients with schizophrenia.难治性精神分裂症患者的管理
J Clin Psychiatry. 1996;57 Suppl 11:26-30.
6
Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.“非典型”抗精神病药物联合应用于难治性精神分裂症和分裂情感性障碍的治疗
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):89-98. doi: 10.1016/j.pnpbp.2003.09.024.
7
Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.精神分裂症门诊患者对氯氮平和利培酮治疗的主观反应。
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):301-5. doi: 10.1016/j.pnpbp.2005.10.006. Epub 2005 Nov 23.
8
A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.一项为期12周的多奈哌齐辅助利培酮治疗慢性稳定型精神分裂症的双盲、安慰剂对照试验。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1810-5. doi: 10.1016/j.pnpbp.2008.08.001. Epub 2008 Aug 7.
9
Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.利培酮作为氯氮平治疗慢性精神分裂症患者的辅助用药。
J Clin Psychiatry. 1996 Sep;57(9):395-7.
10
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.利培酮对精神分裂症和分裂情感性障碍的认知及精神运动作用。
Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014.

引用本文的文献

1
Immunoinflammatory features and cognitive function in treatment-resistant schizophrenia: unraveling distinct patterns in clozapine-resistant patients.难治性精神分裂症的免疫炎症特征与认知功能:揭示氯氮平抵抗患者的不同模式
Eur Arch Psychiatry Clin Neurosci. 2024 Aug 28. doi: 10.1007/s00406-024-01885-x.
2
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.氨磺必利增效治疗改善氯氮平难治性精神分裂症患者的认知功能和精神病理学:一项 12 周随机、双盲、安慰剂对照试验。
Mil Med Res. 2022 Oct 18;9(1):59. doi: 10.1186/s40779-022-00420-0.
3
Avatar Therapy for people with schizophrenia or related disorders.
针对精神分裂症或相关障碍患者的阿凡达疗法。
Cochrane Database Syst Rev. 2020 May 8;5(5):CD011898. doi: 10.1002/14651858.CD011898.pub2.
4
Improving inpatient mental health medication safety through the process of obtaining HIMSS Stage 7: a case report.通过获得医疗卫生信息与管理系统协会(HIMSS)7级认证的过程提高住院患者精神科用药安全性:病例报告
JAMIA Open. 2018 Sep 19;2(1):35-39. doi: 10.1093/jamiaopen/ooy044. eCollection 2019 Apr.
5
Adaptation of a peer based online emotional support program as an adjunct to treatment for people with schizophrenia-spectrum disorders.将基于同伴的在线情感支持项目改编为精神分裂症谱系障碍患者治疗的辅助手段。
Internet Interv. 2016 Mar 29;4:35-42. doi: 10.1016/j.invent.2016.03.003. eCollection 2016 May.
6
Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.维生素 D 补充治疗氯氮平治疗慢性精神分裂症患者的随机、双盲、安慰剂对照临床试验。
EBioMedicine. 2017 Dec;26:138-145. doi: 10.1016/j.ebiom.2017.11.027. Epub 2017 Dec 2.
7
Guidelines for the Pharmacotherapy of Schizophrenia in Adults.成人精神分裂症的药物治疗指南。
Can J Psychiatry. 2017 Sep;62(9):604-616. doi: 10.1177/0706743717720448. Epub 2017 Jul 13.
8
Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report.氯氮平治疗难治性精神分裂症合并肥厚型心肌病1例报告
BJPsych Open. 2016 Dec 14;2(6):390-393. doi: 10.1192/bjpo.bp.116.003723. eCollection 2016 Nov.
9
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review.难治性精神分裂症与反应性精神分裂症在类别上有明显区别吗?一项系统综述。
BMC Psychiatry. 2017 Jan 13;17(1):12. doi: 10.1186/s12888-016-1177-y.
10
Understanding the paranoid psychosis of James: Use of the repertory grid technique for case conceptualization.理解詹姆斯的偏执型精神病:应用纲要图示技术进行案例概念化。
World J Psychiatry. 2016 Sep 22;6(3):381-90. doi: 10.5498/wjp.v6.i3.381.